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Abstract Eosinophilic bronchitis is a recentlydescribed condition inpatientswith chronic cough, sputumeosinophilia,
normal spirometryandno evidence of bronchialhyperreactivity.The aimofthe studywas to assess the causes ofchronic
cough and to identify the prevalence of eosinophilic bronchitis as a cause of chronic cough.Thirty-six patients [mean age
45.4714.3 years (range16^69 years),M/F: 4/32] with an isolated chronic cough lasting formore than 4 weeks were re-
cruited from the outpatient clinic. In all patients, after a full history and physical examination, blood eosinophil count,
eosinophilic cationic protein (ECP), serumtotal and specific IgE levelsweremeasured.Spirometry, methacholineprovo-
cationtest, skinprick tests, ear, nose and throatexamination, induction of sputumand esophagealpHtestingwere per-
formed.The mean duration of cough was 31.3752.3 months. Sputum eosinophilia greater than 3% was present in 12
(33.3%) patients and they were diagnosed as eosinophilic bronchitis.Their induced sputumhad amean eosinophil count
of 8.3% and a mean ECP level of 98.5mg.l-1, which were higher than the others (P=0.003, both).The diagnosis of the
remainingpatientswerepostnasaldrip syndromeineight, gastroesophagealrefluxdiseaseineight, post-infectiouscough
in two and cough-variant asthma in one patient. In conclusion, eosinophilic bronchitis is an important cause of chronic
cough and should be considered in the assessmentof patients before regarding them as having idiopathic chronic cough.
r 2003 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2003.1503, available online at http://www.sciencedirect.com
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Chronic cough is an important and di⁄cult clinical pro-
blem for physicians. In patients seeking medical atten-
tion, the most common causes of chronic cough in
nonsmokers are postnasal drip syndrome (PNDS),
cough-variant asthma (CVA) and gastroesophageal re-
£ux disease (GERD). Chronic cough is often simulta-
neously due to more than one condition (1,2). However,
in many patients, no associated clinical conditions are
present and this group is usually labeled as idiopathic
chronic cough (3).
Gibson and colleagues (4,5), described a group of pa-
tients with corticosteroid-responsive chronic cough
who had sputum evidence of an eosinophilic bronchitis
like asthma, but unlike asthma these patients had no ob-
jective evidence of variable air£ow obstruction or bron-
chial hyperreactivity (BHR). It has been shown that
eosinophilic bronchitis is the cause of cough in 10^20%Received 8 May 2002, accepted in revised form 4November 2002
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E-mail address: okacmaz@med.ege.edu.trof patients presenting to a respiratory specialist (2,6). It
is important to know how commonly eosinophilic bron-
chitis causes chronic cough, since in contrast to cough in
patients without sputum eosinophilia, the former re-
sponds well to corticosteroids (7).
The aim of this study was to identify the prevalence of
eosinophilic bronchitis as a cause of chronic cough.We
used the diagnostic algorithm that was modi¢ed by
Brightling (6) for patients with cough lasting more than
4 weeks in evaluating the causes of chronic cough.
We also compared the clinical and laboratory ¢ndings of
the patients with eosinophilic bronchitis to the other
coughers.
METHODS
Study subjects
Between September 2000 andApril 2001, all thepatients
presenting to our outpatient clinic with an isolated
chronic cough lastingmore than 4weekswere evaluated
for the screening criteria. Forty-three of themwere eli-
gible and included in the study. The criteria of inclusion
were: (1) no symptoms other than chronic cough, (2) no
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respiratory tract infection within 1 month, (4) normal
chest radiograph, (5) normal physical examination of
the chest, (6) normal spirometric values, (7) in the bron-
chial provocation test, methacholine provocative con-
centration (PC20) causing a 20% fall in forced expiratory
volume in 1s (FEV1)4 8mgml
1. Former smokers who
had smoked more than 8 pack-years, current smokers
and patients under angiotensin-converting enzyme inhi-
bitor (ACEI) treatment were excluded from the study.
All patients gave informed consent to participate in the
study.
As the aim of the study was to assess the causes of
chronic cough andespecially to identify the subjectswith
eosinophilic bronchitis, there was no control group.
However, the clinical and laboratory ¢ndings of the pa-
tients with and without eosinophilic bronchitis were
compared to each other.
Study design
Patients were evaluated on two occasions. In the ¢rst
visit, a full history was taken; previousmedical problems,
medications and smoking history were recorded. After
physical examination, spirometry and if this was re-
garded as normal, bronchial provocation test with
methacholine was performed. Besides, blood eosinophil
count, Eosinophilic Cationic Protein (ECP), serum total
and speci¢c IgE levelsweremeasured. Allergen skin prick
test and stool examination for parasites were obtained.
The second evaluation was done within 2 weeks and
included ear, nose and throat (ENT) examination, induc-
tion of sputum and 24h esophageal pH testing.
Pulmonary function testing
Spirometry was performedwith awater-sealed spirom-
eter (SensorMedics 2400). At least three reproducible
values were obtained and the highest value was used in
the analysis. If FEV1was higher than 80% and/or the ratio
of FEV1/FVC (forced vital capacity) was higher than 75%,
the spirometry was regarded as normal. Subjects with a
normal spirometry then underwent a methacholine
bronchial provocation test. Patients with PC20 below
8mg.ml1were considered as having BHR andno further
examinations were done.
Ear, nose and throat examination
An ENT consultant who was blinded to the patients’
symptoms and previously documented ¢ndings per-
formed ear, nose and throat examination.Upper respira-
tory signs and symptoms like drainage in posterior
pharynx, throat clearing, thickle in the throat; headache,
nasal discharge andobstruction suggestive of allergic rhi-nitis, chronic sinusitis and pharyngitis were all recorded.
Anterior andposterior rhinoscopic examination ¢ndings
were evaluated. Sinus radiographs inWaters projection
were obtained and assessed for air-£uid levels, opaci¢ca-
tion ormucosal thickening in the sinus.
Allergen skin prick testing
Allergen skin sensitivity wasmeasuredby skin prick test-
ing for common aeroallergens like house dustmites, pol-
lens, animals and molds, with controls consisting of
normal saline andhistamine (Stallergenes, France). A po-
sitive response to an allergen on the skin prick tests was
recorded in the presence of a wheal measuring 50^75%
more than the induration of histamine.
Esophagealmanometry andambulatory 24h
esophageal pHtesting
Treatmentwith acid-suppressingmedications like H2-re-
ceptor antagonists and proton pump inhibitors and cer-
tain type of foods, drinks, alcohol and tobacco were
withheld for at least 7 days before the test. After an
overnight fast, all patients underwent esophageal mano-
metry in order to identify the location of the lower eso-
phageal sphincter (LES).
Ambulatory pHmonitoring of the esophaguswas per-
formedwith a catheter containing two antimonypH sen-
sors. The antimony pH electrodes were calibrated in
bu¡er solutions of pH 7 and 1. The catheter was intro-
duced through the nose and into the stomach initially
and then slowly withdrawn until distal probe was posi-
tioned 5 cm and the proximal probe was placed 20 cm
above the LES. After 24hpHrecording, dataweredown-
loaded into a computer (Gastrograph Mark 2,USA) and
analyzed separately for the proximal and distal esopha-
geal pH electrodes by a diagnostic software package
(Polygram FunctionTesting Software, Medtronic, USA).
During 24h when esophageal pH was being recorded,
subjects were encouraged to continue their usual daily
activities. Analysis was performed to determine the per-
centage of time when pH level was below 4 and total
number of re£ux episodes during 24h, both in upright
and supinepositions forbothproximal anddistal electro-
des.DeMeester scorewas used in the evaluation of distal
sensor (8): abnormal amounts of acidre£ux were consid-
ered tobepresent in the distal esophagus if the totalper-
cent time pHo4 exceeded 4.2% during the 24h study
period, or upright acid exposure exceeded 6.3%, or su-
pine acid exposure exceeded 1.2% and total re£ux epi-
sodes 450 and duration of the longest re£ux episode
49.2min (DeMeester score). Abnormal amounts of
proximal re£ux occurred if the total percent time
pHo4 exceeded1.1%, or upright acid exposure exceeded
1.7%, or supine acid exposure exceeded 0.6% and total
TABLE 1. Characteristics of the patients with chronic
cough.
Age (years)* 45.4714.3 (16^69)
Sex,M/F (n)w 4 (11%)/32 (89%)
Duration of cough, months* 31.3752.3 (1^240)
FEV1 (% pred)
* 109.4714.6 (88^139)
Methacholine
PC20=8, mg.ml
1 (n)w
4 (11%)
Blood eosinophil (%)* 1.771.1 (0.2^4.8)
Blood ECP (mgl1)* 13.378.6 (2^40)
IgE (KUl1)* 56.9785.3 (3^489)
*Values are expressed asmean7SD (range).
wValues are given as the numberof patients (%).
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episode43min. As therewas no de¢ned score for prox-
imal sensor, itwas assessed asproximal re£ux in thepre-
sence of two of the ¢ve criteria.
Sputum induction
Sputum was induced and processed as previously de-
scribed (9,10). After 200mg salbutamol inhalation, spu-
tum was induced using 5^7ml of 3% hypertonic saline
for 5^7 min via an ultrasonic nebulizer (SonoDrop,Tru-
ma, Germany; output: 2.5ml/min; median particle size:
4.5mm). Patients blew their noses and rinsed their
mouths to minimize nasal contamination and expecto-
rated sputum into a sterile pot. If adequate amount of
sputum samples could not be collected, the same proce-
durewas repeatedonce or twice immediatelyby inhaling
the same concentration (3%) of aerosolized hypertonic
saline over increasing time periods.
Sputum, free from salivary contamination was se-
lected and 2ml of Hanks’ balanced salt solution (HBSS)
containing 0.1% dithiothrietolwere added to the sputum.
The samples were vortexed and repeatedly aspirated
through a small-bore pipette until they were completely
homogenized. The sputum volume was then recorded
and further diluted with HBSS up to 10ml, vortexed
brie£y and centrifuged at1800 rpm for10min.The super-
natants of the sputumwerekept at701C formeasuring
ECP. Slideswereprepared for di¡erential cell counts.The
sputum andblood concentrations of ECPweremeasured
using a commercial £uoroimmunassay (ECP Fluroimmu-
nassay, Pharmacia &Unicap Diagnostics AB, Sweden).
Statistical analysis
Data were entered into a statistical software package
(SPSS 10.0 for Windows). For parametric measures Stu-
dent’s t-test was used. Analysis of categorical variables
was done using Chi-Square Test or Fisher’s Exact Test.
The association between variables was examined by
Pearson correlation analysis. Avalue of Po0.05 was con-
sidered signi¢cant for all statistical analysis.
RESULTS
Between September 2000 andApril 2001, all thepatients
presenting to our outpatient clinic with an isolated
chronic cough lastingmore than 4weekswere evaluated
for the screening criteria. Forty-three of themwere eli-
gible and included in the study. However, seven patients
were excluded during the study period as four patients
refused to undergo sputum induction and 24h esopha-
geal pH testing, one patient moved to another city, one
patient’s symptoms recoveredbefore the diagnostic pro-
cedureswere completed andonepatientwhohadhyper-tension before, had a sudden attack of hypertension
during sputum induction as he thought that he should
come to thehospital in a fasting state andhe didnot take
his anti-hypertensive drug that morning. The remaining
36 patients (32 females and four males) with a mean age
45.4714.3 years (range 16^69 years) completed the
study. The mean duration of chronic cough was
31.3752.3 months (range 1^240 months). There was a
co-existing disease in 10 (27.8%) patients: hypertension
in ¢ve (no ACEI use), diabetes mellitus in three, athero-
sclerotic heart disease and rheumatoid arthritis in one
patient, each. High-resolution computed tomography of
the patientwith rheumatoid arthritis showedno lung in-
volvement.
The mean blood eosinophil percentage was 1.7% and
blood eosinophilia greater than 3% was present in three
(8.3%) patients. Blood ECP levels lower than 11mg.l1
were regarded as normal. The mean blood ECP level
was 13.3mg.l1 and 16 (44.4%) patients had higher levels
thannormal value.Nine of them also had sputumeosino-
philia. Allergen skin prick tests were positive in seven
(19.4%) patients.Total IgEwas high in ¢ve (13.9%) and spe-
ci¢c IgE was positive in two patients. Stool examinations
for parasites were positive in two patients and one of
them also had blood eosinophilia, but no sputum eosino-
philia. The characteristics of the patients are shown in
Table1.
ENT examinations of 28 patients were normal and
eight (22.2%) patients had PNDS ¢ndings: chronic phar-
yngitis in seven and rhinitis in one of them. Sinus radio-
graphs of 28 patients were normal; there were mucosal
thickening in ¢ve and less aerated sinus in three patients.
ENTexamination and radiographic ¢ndings of the sinus
correlated in only three patients.
Seven patients could not tolerate the 24h esophageal
pH testing. Out of the 29 patients who underwent the
pH test, there were proximal re£ux in seven and distal
re£ux in three patients. Five patients had both proximal
and distal re£ux, so the total number of patients with
698 RESPIRATORYMEDICINEgastroesophageal re£ux was 15 (51.7%). However, as
there was no de¢ned score for proximal re£ux, we only
took eight patients with distal re£ux into account.There
was no signi¢cant di¡erence in terms of age, sex, dura-
tion of cough, blood eosinophil, IgE and ECP values be-
tween those with and without distal gastroesophageal
re£ux. However, percentage of eosinophils and ECP le-
vels in the induced sputum were higher in the patients
who had no gastroesophageal re£ux (P=0.01 and
P=0.001, respectively) (Table 2).
Sputum induction was performed in all patients. In
four patients the procedure was repeated three times,
but they were unable to produce su⁄cient amount of
sputum for analysis. In the remaining 32 patients, median
sputum macrophage, neutrophil, lymphocyte and eosi-
nophil percentages were 61.8, 24.8,10.3 and 3.4%, respec-
tively. Sputum eosinophilia greater than 3% was present
in12 of these 32 patients and they were diagnosed as eo-
sinophilic bronchitis. There was also PNDS in three of
them. Their mean sputum eosinophil percentage was
8.3%, which was much higher than the other patients
(P=0.003). Sputum di¡erential cell counts of the patients
with and without eosinophilic bronchitis are shown in
Fig. 1. When patients with eosinophilic bronchitis and
those without sputum eosinophilia were compared to
each other, no signi¢cant di¡erence in age, sex, duration
of cough, presence of co-morbidity, pulmonary function
test, blood eosinophil count, total IgE, speci¢c IgE and
allergen skin sensitivity was found (P40.05). The mean
blood ECP level of patients who had eosinophilic bron-
chitis was higher than the patients with no eosinophilia
(16.276.5 and 11.077.0 respectively, P=0.05). There was
also a signi¢cant di¡erence in the mean ECP levels of in-
duced sputum between patients with and without eosi-
nophilic bronchitis (98.5761.5 and 30.5735.5,TABLE 2. Characteristics ofthe patientswith andwithoutgastr
Patientswith GER
Age (years)* 40.8714.1
Sex,M/F (n)w 1/7
Duration of cough, months* 22.3725.1
FEV1 (% pred)
* 113.8717.5
Methacholine PC20=8 mg.ml
-1(n)w 0
Blood eosinophil (%)* 1.470.5
Blood ECP (mgl1)* 13.6712.3
IgE (KUl1)* 39.8737.4
Sputumeosinophil (%)* 070
Sputummacrophage (%)* 66.4711.8
Sputumneutrophil (%)* 24.9713.5
Sputumlymphocyte (%)* 10.074.1
Sputum ECP (mgl1)* 13.579.1
*Values are expressed asmean7SD.
wValues are given as the numberof patients.respectively, P=0.003) (Table 3). Four patients who had
the highest levels of sputum eosinophilia underwent ¢-
beroptic bronchoscopy for bronchoalveolar lavage
(BAL) examination and no eosinophilia was detected in
the BAL £uid analysis.
When all the causes of chronic coughwere evaluated,
it was seen that 12 (33.3%) patients were diagnosed as
having eosinophilic bronchitis, eight (22.2%) patients as
PNDS, eight (22.2%) patients as GERD, two (5.6%) pa-
tients as post-infectious cough and one (2.8%) patient as
cough-variant asthma. Three cases with eosinophilic
bronchitis also had PNDS. A diagnosis leading to a suc-
cessful treatment was reached in 28 (77.7%) cases. In
spite of all diagnostic procedures, the causes of chronic
cough could not be identi¢ed in eight (22.2%) patients
and they were considered to have idiopathic chronic
cough (Table 4).
DISCUSSION
Irwin and colleagues (11,12) suggested an anatomic-diag-
nostic approach for identifying the causes of chronic
cough. Brightling and colleagues (6) modi¢ed this proto-
col to look for evidence of eosinophilic bronchitis and
added the analysis of induced sputum to the other proce-
dures. In this study, weused thismodi¢edprotocol in pa-
tients with an isolated chronic cough lastingmore than 4
weeks and identi¢ed the cause or causes of chronic
cough in 28 (77.8%) patients. Eosinophilic bronchitis was
the cause of chronic cough in12 (33.3%) of them.Diagno-
sis of other patients was postnasal drip syndrome
(22.2%), gastroesophageal re£ux disease (22.2%), post-
infectious cough (5.6%) andcough-variant asthma (2.8%).oesophagealre£ux (GER).
(n:8) Patientswithout GER (n: 21) P
46.6712.6 0.29
2/19 0.55
34.3756.9 0.57
107.9714.7 0.36
4 0.55
1.971.2 0.27
12.977.7 0.85
66.17107.5 0.54
4.777.1 0.01
60.9716.8 0.44
22.8714.1 0.74
11.679.9 0.69
61.1754.9 0.001
FIG. 1. Sputumdi¡erential cell counts of patientswith andwithouteosinophilic bronchitis (EB).
TABLE 3. Characteristics ofthe patientswith andwithouteosinophilic bronchitis (EB).
Patientswith EB (n:12) Patientswithout EB (n:20) P
Age, yrs* 48.8713.3 43.3714.5 0.30
Sex,M/F (n)w 2/10 2/18 0.61
Duration of cough (months)* 16.6722.4 43.3764.3 0.18
Co-morbidity (yes/no) (n)w 3/9 4/16 0.69
FEV1 (% pred)
* 111.8714.3 109.9715.0 0.73
Methacholine PC20=8 mg.ml
-1(n)w 1 3 1.00
Blood eosinophil (%)* 1.471.0 1.971.1 0.19
Blood ECP (mg.l-1)* 16.276.5 11.077.0 0.05
IgE (KU.l-1)* 46.5741.1 54.47110.3 0.81
Speci¢c IgE (7) (n)w 0/12 2/18 0.51
Allergen skin sensitivity (7) (n)(+/) 2/10 3/17 1.0
Sputumeosinophil (%)* 8.377.2 0.471.0 0.003
Sputummacrophage (%)* 55.4710.1 65.6715.9 0.05
Sputumneutrophil (%)* 27.9712.3 22.7713.7 0.14
Sputumlymphocyte (%)* 7.574.0 12.179.2 0.11
Sputum ECP (mgl1)* 98.5761.5 30.5735.5 0.003
*Values are expressed asmean7SD.
wValues are given as thenumberof patients.
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in 77.8% of the study patients, a success rate similar to
the previous studies (2,6,12^15).This rate may have been
higher, if we had not excluded the patients who hadupper respiratory tract infection in the previous month
and a historyof a respiratorydisease like asthma, chronic
bronchitis, bronchiectasis, who usedmedications known
to induce chronic cough and the ones with a positive
TABLE 4. Causes of chronic cough.
Primarycause of cough No. of patients (%)*
Eosinophilic bronchitis 12 (33.3)
Postnasal drip syndrome 8 (22.2)
Gastroesophagealre£ux 8 (22.2)
Idiopathic chronic cough 8 (22.2)
Post-infectious cough 2 (5.6)
Cough-variant asthma 1 (2.8)
*Three patients had both eosinophilic bronchitis and
postnasal drip syndrome.
700 RESPIRATORYMEDICINEmethacholine challenge test (PC20 o8mgml1). How-
ever, the aim of this study was especially to identify the
subjects with eosinophilic bronchitis. So, asthma, angio-
tensin-converting enzyme inhibitor-induced cough and
most of the post-infectious cough and cough-variant
asthma cases were not included.
In our study, eight of 29 patients who underwent pH
testing were evaluated as distal gastroesophageal re£ux
and12 patients as proximal re£ux (¢ve of them also had
distal re£ux). As therewas no de¢ned score for proximal
re£ux, we only tookeightpatientswith distal re£ux into
account.Therewas no signi¢cantdi¡erencebetween the
patients with distal gastroesophageal re£ux and the
others. But the percentage of eosinophils and ECP levels
in induced sputum were higher in the patients who had
no gastroesophageal re£ux. McGarvey (16) reported
that eosinophil numbers were increased in BAL £uid
frompatients with GER-related cough and GERD should
be excluded if the only cause of chronic cough was de-
tected as eosinophilic bronchitis. Micheletto (17) mea-
sured elevated levels of ECP in induced sputum from
non-asthmatic cougherswithGERD.However, Parames-
waran etal. (18) evaluated the association of GER and air-
way in£ammation in chronic cough and asthma. They
examined the airway in£ammatory indexes in induced
sputum and exhaled air of patients with cough and GER,
asthma and GER, asthma without GER and of healthy
controls.The sputum eosinophil andmetachromatic cell
percentages and ECP levelswere normal in patientswith
cough and GER.They were signi¢cantly increased in pa-
tientswith asthma compared to the healthy subjects and
patients with cough, but were not di¡erent between
groups with and without GER. They concluded that
GER, when associated with cough or asthma, does not
cause or aggravate existing airway in£ammation. So, in-
£ammation of the airway in thepatientswithGERis con-
troversial in the literature. In our study, we found that
the percentage of sputum eosinophils and ECP levels of
patients with GERwere lower than the others and none
of the patients with eosinophilic bronchitis had GERD.
As 12 of the patients without re£ux had eosinophilic
bronchitis, we could say that nearly half of our patientswithout GER had eosinophilic bronchitis andmaybe this
could be the explanation of higher eosinophils in the pa-
tients without distal re£ux.
We found that eight (22.2%) patients had PNDS ¢nd-
ings. Seven of themwere chronic pharyngitis and one of
themwasrhinitis.Eosinophilic bronchitiswas detectedin
three of these patients. So, PNDS and GERD were the
second common causes of chronic cough in this study.
In 1989 Gibson et al. (4) ¢rst described eosinophilic
bronchitis in a group of patientswith chronic cough, spu-
tum eosinophilia, normal spirometry and no evidence of
BHR. It is important to know how commonly eosinophi-
lic bronchitis is the cause of chronic cough, since it re-
sponds well to corticosteroids in contrast to patients
with chronic cough and no sputum eosinophilia (6,7).
Current algorithms for investigating chronic cough do
not include assessment of airway in£ammation.We used
induced sputum in order to evaluate the airway in£am-
mation and detected eosinophilic in£ammation in 13 pa-
tients. One of them was diagnosed as having cough-
variant asthmabecause of BHR and allergen skin test po-
sitivity.However, it would have been better if we had re-
cruited thepatientswith PC20o16mg.ml1andexcluded
this patient from the study.
Eosinophilic bronchitis was the underlying cause of
chronic cough in12 (33.3%) patients with sputum eosino-
philia and treatmentwith inhaled steroidwas given to all
of them.The clinical and laboratory ¢ndings of these pa-
tients were not di¡erent except for sputum eosinophil
and ECP levels, whichweremuchhigher than the others.
Carney (2) and Brightling (6) have shown that eosinophi-
lic bronchitis is the cause of chronic cough in10% and13%
of patients, respectively. In the second study, sputum in-
ductionwas performed only in the undiagnosed patients
and if it had been used in all of them, more eosinophilic
bronchitis cases could have been detected. In a recent
study by Lee and colleagues, (19) 25 patients who had
chronic nonproductive cough as an isolated symptom
and no other potential causes of chronic cough were
evaluated. Instead of induced sputum, bronchoscopic
biopsies were performed in order to assess the airway
in£ammation and 21 patients who had eosinophilic in-
£ammationwere de¢ned as eosinophil-in¢ltrated group.
Five of them were diagnosed as cough-variant asthma
due to positive results in the methacholine challenge
test. The remaining 16 (64%) patients of the eosinophil-
in¢ltrated group with no BHRwere assessed as eosino-
philic bronchitis and this rate was much higher than the
previous studies. A plausible explanation of this can be
the recruitment of the patients who had idiopathic
chronic cough only and exclusion of the ones with other
causes of chronic cough.They also reported that four of
25 patients with chronic cough revealed higher median
lymphocyte count than the healthy controls (median
84.5 vs. 22.0 cells/mm (3), respectively) and assessed
these patients as lymphocyte-in¢ltrated subjects. In our
TRANSMISSIONOFLAYEREDVIDEOSTREAMOVERTHE INTERNET 701study, sputumlymphocyteswere somewhathigher in the
patients without eosinophilic bronchitis, although it was
not statistically signi¢cant. Fujimoto et al. (20) reported
similar results and they found that thepercentage of spu-
tum lymphocytes was 6.7% in healthy subjects and 6.2%
in asthmatic patients.Maybe, just like eosinophilic bron-
chitis, a new clinical condition can be described in pa-
tients with chronic cough, which will be called as
‘‘lymphocytic bronchitis’’in the future.
In conclusion, eosinophilic bronchitis is a recently re-
cognized condition and systemic approach for the diag-
nosis of chronic cough did not previously include
assessment of airway in£ammation by induced sputum.
These patients were regarded as idiopathic chronic
cough or as cough-variant asthma because of their posi-
tive response to corticosteroids.For all these reasons, it
is estimated that there are more cases of undiagnosed
eosinophilic bronchitis and further studies will show the
exact prevalence, natural history and long-term prog-
nosis of this new disease.
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